MENU
HELP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cybin (HELP) Ownership - Who owns Cybin?

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
232.49M
P/E Ratio
N/A
Total Cash
195.13M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.14
Dividend Yield
N/A
Total Cash/Share
3.91
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
HELP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details